Psoriasis and dermatitis (commonly called eczema) both cause red, itchy, inflamed skin, but they arise from fundamentally different problems in the body. Psoriasis is driven by an overactive immune system that speeds up skin cell production, while dermatitis stems from a weakened skin barrier that lets irritants and allergens trigger inflammation. That distinction shapes everything from how the rashes look and where they appear to how they’re treated.
What’s Happening Under the Skin
In psoriasis, the immune system sends faulty signals that dramatically accelerate skin cell turnover. Normal skin replaces itself roughly every 23 days. In psoriatic skin, that cycle compresses to just 3 to 5 days. Cells pile up faster than the body can shed them, forming the thick, raised plaques the condition is known for. This is an autoimmune process, meaning the body is essentially attacking its own tissue without any external allergen needed to set it off.
Atopic dermatitis works differently. A key protein called filaggrin helps maintain the skin’s outer barrier by retaining moisture and keeping its structure intact. Many people with eczema have reduced filaggrin levels, either from genetic mutations or from inflammation that suppresses the protein’s production. The result is skin that loses water more easily and allows irritants, allergens, and bacteria to penetrate. That breach triggers the immune system, which responds with inflammation and intense itching. Notably, filaggrin deficiency varies across populations: African American patients with eczema often have normal filaggrin levels, suggesting other barrier defects are at work too.
How the Rashes Look and Feel
The visual differences between the two can be subtle in mild cases but become clearer as severity increases. Psoriasis produces well-defined, raised plaques with sharp borders that stand out distinctly from surrounding skin. Classic plaque psoriasis has a characteristic silvery-white scale on top. These plaques are thick enough to crack and bleed, particularly when scratched or when skin is dry.
Dermatitis patches tend to have less defined edges that blend more gradually into normal skin. The affected areas often look red, swollen, and raw rather than raised and scaly. When scaling does occur in certain types of dermatitis, like seborrheic dermatitis on the scalp, the scales are greasy and yellowish rather than dry and silvery.
Both conditions itch, but the sensation differs. Eczema typically produces more intense itching, often severe enough to disrupt sleep. Psoriasis can itch too, but it’s more commonly described as a burning or stinging sensation. Low humidity worsens both, drying out skin and amplifying discomfort, while heat and sweating can also trigger flares.
Where Each Condition Appears on the Body
One of the most reliable ways to tell the two apart is location. Psoriasis favors extensor surfaces, the outer sides of joints. Think the front of the knees, the outside of the elbows, and the shins. It also commonly affects the scalp, lower back, and nails. Dermatitis gravitates toward flexural surfaces, the inner creases where skin folds. The crook of the elbows and the backs of the knees are classic eczema territory.
Both conditions can show up on the face, hands, and feet, so location alone isn’t always enough to distinguish them. But when a rash sits squarely on the outside of the elbows with thick silvery scales, or nestles into the inner elbow crease with raw, weeping skin, the pattern points strongly in one direction.
Different Triggers, Different Flares
What sets off a flare is another area where the two diverge. Psoriasis triggers are often internal or immune-related. Strep throat is a well-established trigger for a specific form called guttate psoriasis, which causes a sudden eruption of small, drop-shaped spots. Stress, certain medications, and skin injuries can also provoke flares. Psoriasis exhibits something called the Koebner phenomenon, where new plaques form at sites of skin trauma like cuts, scrapes, or even sunburn.
Dermatitis flares are more commonly tied to external exposures. Allergens like dust mites, pet dander, pollen, and certain foods can trigger or worsen eczema. Harsh soaps, fragrances, and rough fabrics are frequent culprits. Bacterial colonization on the skin, particularly by staph bacteria, contributes to eczema progression and can make flares harder to control. The condition is closely linked to other allergic diseases, forming what’s sometimes called the atopic triad: eczema, asthma, and hay fever.
Health Risks Beyond the Skin
Psoriasis and dermatitis are both more than skin conditions. Each carries its own set of associated health risks, and understanding these matters for long-term management.
Psoriasis is strongly associated with inflammatory joint disease. Up to 30% of people with psoriasis develop psoriatic arthritis, which causes pain, stiffness, and swelling in the joints. The condition also increases the risk of other autoimmune diseases, including certain autoimmune skin conditions and connective tissue disorders. Cardiovascular risk is elevated as well, driven by the chronic systemic inflammation psoriasis produces.
Atopic dermatitis is linked to the atopic triad: asthma and allergic rhinitis (hay fever) frequently coexist with eczema, particularly when it begins in childhood. Interestingly, the overlap between the two conditions is broader than once thought. Research shows that asthma and allergic rhinitis also occur at higher rates in people with psoriasis, and autoimmune diseases like rheumatoid arthritis are seen in both groups. Still, the pattern holds: if you have eczema, watch for respiratory allergies; if you have psoriasis, watch your joints.
How Each Condition Is Treated
Because the underlying mechanisms differ, treatments diverge in important ways, even though some basic strategies overlap.
Both conditions benefit from consistent moisturizing, gentle skin care, and avoiding known triggers. Topical corticosteroids are a first-line treatment for both, reducing inflammation and calming flares. Beyond that, the paths split.
Psoriasis treatments often target the overactive immune pathways driving skin cell overproduction. Phototherapy (controlled UV light exposure) is a common option for moderate psoriasis. For more severe cases, biologic therapies that block specific immune signals have transformed treatment. These injectable medications target different parts of the inflammatory cascade and are specifically approved for psoriasis.
Atopic dermatitis treatment focuses more on repairing and protecting the skin barrier alongside controlling immune overreaction. Keeping the skin well-hydrated is not just comfort care but a core part of treatment. For moderate to severe eczema, a biologic that targets a different immune pathway than the ones used in psoriasis was approved specifically for atopic dermatitis. The two conditions require different biologics because different branches of the immune system are involved: psoriasis is driven more by one set of immune cells and signaling molecules, while eczema is driven by another.
When It’s Hard to Tell Them Apart
In some cases, especially on the scalp or in skin folds, psoriasis and dermatitis can look nearly identical. Inverse psoriasis, which appears in skin creases rather than on outer joint surfaces, produces smooth, shiny, moist plaques without the telltale silvery scale, making it easy to confuse with eczema or seborrheic dermatitis.
When a visual exam isn’t enough, a skin biopsy can help. Under a microscope, psoriasis shows distinctive features: evenly elongated ridges in the skin’s outer layer and clusters of immune cells within layers of abnormal skin cells. The rate of cell division is markedly higher in psoriatic tissue. Seborrheic dermatitis, by contrast, shows plugged hair follicles and a different pattern of immune cell activity. These microscopic differences give pathologists a reliable way to distinguish conditions that can look identical to the naked eye.
Prevalence and Who Gets Each
Psoriasis affects between 0.4% and 8% of the global population, with rates varying significantly by region. It can start at any age but has two common onset peaks: one in the late teens to mid-20s and another in the 50s and 60s. It affects men and women equally.
Atopic dermatitis is more common overall, particularly in children. It affects roughly 10% to 20% of children worldwide, though many outgrow it or see significant improvement by adulthood. When it persists or starts in adulthood, it tends to be more stubborn. Both conditions run in families, but eczema’s genetic component is more closely tied to skin barrier genes, while psoriasis risk genes cluster around immune function.